INVO Fertility expands its stock‑incentive plan with 800,000 new shares, boosting employee perks and talent attraction in the fertility treatment sector.
INVO Fertility Inc, a medical device company specializing in fertility treatment and patient care solutions, navigates the complex and rapidly evolving fertility treatment landscape, driven by growing demand and innovative technologies.
INVO Fertility Inc faces challenges in the fertility treatment industry, including a recent embryo transfer incident at Monash IVF, which highlights the need for improved procedural safeguards and patient support systems.